A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patients with Advanced Epithelial Ovarian, Fallopian Tub
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Gynecologic Oncology Group
Start Date
December 7, 2020
End Date
September 1, 2025
Administered By
Duke Cancer Institute
Awarded By
Gynecologic Oncology Group
Start Date
December 7, 2020
End Date
September 1, 2025